Amarin Seeks ITC Action Against Products 'Cloaked' As Dietary Supplements

 
• By Sue Sutter

Seeking to protect its competitive interests, Vascepa marketer asks the US International Trade Commission to investigate importation and sale of synthetically produced omega-3 products by 18 companies; complaint asserts the products at issue are unapproved new drugs that are illegally being marketed as dietary supplements.

US International Trade Commission ITC in Washington DC
Amarin seeks ITC review of 18 companies' omega0-3 products.

More from Legal & IP

More from Pink Sheet